This project is aimed at developing a molecular genetic approach for the study; classification and diagnosis of human lymphoid neoplasms including non Hodgkin's Lymphomas (NHL) and lymphoid leukemia (LL). This approach will be based on the analysis of two classes of genetic markers in lymphoid tumors. First, immunoglobulin and T-cell receptor gene rearrangements will be analysed as markers of lineage, clonality and stage of differentiation in B- and T-cell tumors respectively. Second, the expression of known cellular oncogenes will be analyzed as markers of proliferative and differentiative status of the same tumors. The results of both these analyses will correlate with immunopheno-typic, istopathologic and clinical data. In particular the research plan will involve the following specific aims: 1) Classification of stage of B-cell differentiation of lymphomas and leukemias based on Ig gene rearrangements 2) classification of stage of differentiation and functional subtype of T-cell neoplasm based on expression of T-cell receptor genes. This part of the project will involve the development of molecular probes and strategies for the detection of rearrangements of the genes coding for the alpha and gamma chain of the T-cell receptor. 3) Analysis of pattern of oncogene expression in different tumor subtypes and correlation with immunogenotypically determined stages of differentiation. 4) Application of the assays for identification of B- and T-cell clones to a number of important clinical questions including: a) identification of minimal residual disease during tumor remission b) identification of and comparative analysis of clonal populations during different stages, i.e. onset and relapses of a given malignancy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044029-04
Application #
3186538
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1989-07-15
Project End
1990-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Hauptschein, R S; Gaidano, G; Rao, P H et al. (2000) An apparent interlocus gene conversion-like event at a putative tumor suppressor gene locus on human chromosome 6q27 in a Burkitt's lymphoma cell line. DNA Res 7:261-72
Butler, M P; Wang, S I; Chaganti, R S et al. (1999) Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24:322-7
Pasqualucci, L; Migliazza, A; Fracchiolla, N et al. (1998) BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 95:11816-21
Hauptschein, R S; Gamberi, B; Rao, P H et al. (1998) Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types. Genomics 50:170-86
Chaganti, S R; Rao, P H; Chen, W et al. (1998) Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IGH sequences in complex translocations involving band 3q27. Genes Chromosomes Cancer 23:328-36
Chen, W; Butler, M; Rao, P H et al. (1998) The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene. Oncogene 17:1717-22
Chen, W; Iida, S; Louie, D C et al. (1998) Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood 91:603-7
Chaganti, S R; Chen, W; Parsa, N et al. (1998) Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes Chromosomes Cancer 23:323-7
Carbone, A; Gaidano, G; Gloghini, A et al. (1997) BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol 150:155-65
Carbone, A; Gloghini, A; Gaidano, G et al. (1997) BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas. Blood 90:2445-50

Showing the most recent 10 out of 55 publications